LEADER 03595nam 2200625Ia 450 001 9910143303403321 005 20230617005249.0 010 $a1-280-21295-0 010 $a9786610212958 010 $a0-470-99490-8 010 $a1-4051-4681-8 035 $a(CKB)1000000000341898 035 $a(EBL)238458 035 $a(SSID)ssj0000115321 035 $a(PQKBManifestationID)11129702 035 $a(PQKBTitleCode)TC0000115321 035 $a(PQKBWorkID)10010815 035 $a(PQKB)11296755 035 $a(MiAaPQ)EBC238458 035 $a(OCoLC)184983480 035 $a(EXLCZ)991000000000341898 100 $a20040908d2005 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 04$aThe Brugada syndrome$b[electronic resource] $efrom bench to bedside /$fedited by Charles Antzelevitch ; with associate editors Pedro Brugada, Josep Brugada, Ramon Brugada 210 $aOxford $cBlackwell$d2005 215 $a1 online resource (244 p.) 300 $aDescription based upon print version of record. 311 $a1-4051-2778-3 320 $aIncludes bibliographical references and index. 327 $aThe Brugada Syndrome: From Bench to Bedside; Contents; Contributors; Preface; Dedication; 1 Brugada syndrome: overview; 2 History of the Brugada syndrome; 3 Biophysical analysis ofmutant sodium channels in Brugada syndrome; 4 Molecular genetics of the Brugada syndrome; 5 Cellular mechanisms underlying the Brugada syndrome; 6 Brugada syndrome: diagnostic criteria; 7 Value of 12 lead electrocardiogram and derived methodologies in the diagnosis of Brugada disease; 8 Brugada syndrome: relationship to other arrhythmogenic syndromes; 9 ST segment elevation and sudden death in the athlete 327 $a10 Brugada syndrome: role of genetics in clinical practice11 Genotype-phenotype relationship in the Brugada syndrome; 12 Gender differences in Brugada syndrome; 13 Predisposing factors; 14 Acquired forms of Brugada syndrome; 15 Atrial tachyarrhythmias in Brugada syndrome; 16 Prognosis in individuals with Brugada syndrome; 17 Treatment of Brugada syndrome with an implantable cardioverter de.brillator; 18 Pharmacologic approach to therapy of Brugada syndrome: quinidine as an alternative to ICD therapy?; 19 Potential for ablation therapy in patients with Brugada syndrome; Index 330 $aUntil recently, the cellular basis for sudden death, the Brugada Syndrome, has largely remained an unknown to modern arrhythmologists and cardiologists, particularly in the absence of any structural heart disease. Detailed observations of age-groups, especially the young, families and populations where sudden death frequently occurs, and improved understanding of its contributory factors and mechanisms are, however, showing the way forward. This addition to the Clinical Approaches to Tachyarrhythmias (CATA) Series, written by the investigators who discovered and probed the Brugada Syn 606 $aBrugada syndrome 606 $aBundle-branch block 606 $aVentricular tachycardia 615 0$aBrugada syndrome. 615 0$aBundle-branch block. 615 0$aVentricular tachycardia. 676 $a616.123 676 $a616.128 701 $aAntzelevitch$b Charles$0945442 701 $aBrugada$b Pedro$0945443 701 $aBrugada$b J$0945444 701 $aBrugada$b Ramon$0945445 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910143303403321 996 $aThe Brugada syndrome$92134466 997 $aUNINA